I meant to post this response to Pietro's reply to the BB: I agree that bugs in software are an ever-present source of annoyance, but the only software in general use that I'm aware of that can't cope with the conventional ITC-A settings is Arp/Warp (and even this was definitely true only for the previous versions and may have been fixed in the current one which I don't currently have access to).
I'm not aware of any other popular software in general use (this includes all CCP4 software that I'm aware of, and certainly includes Shel-X, CNS & Phenix) that can't cope with the ITC-A settings? It seems to me that the solution is to fix the bug in the software - I can't believe it can be that hard to sort it out (or alternatively of course use different software without that bug, though of course the alternatives may well have different bugs!). Cheers -- Ian > -----Original Message----- > From: Pietro Roversi [mailto:[EMAIL PROTECTED] > Sent: 21 January 2008 11:10 > To: Ian Tickle > Subject: Re: [ccp4bb] Spacegroup choices, reindexing and so on > > Dear Ian, > I would agree with everyhting you say but as luck had > it I have been unfortunate enough to get P21212 and P2221 crystals > lately and you'd be surprised to find out how many pieces of software > could not cope with non-standard settings - at the end I had > to give up > and conform to the norm out of bug exhaustion ... > > Regards > > Pietro > -- > Pietro Roversi > Sir William Dunn School of Pathology, Oxford University > South Parks Road, Oxford OX1 3ER, England UK > Tel. 0044-1865-275385 > > > Disclaimer This communication is confidential and may contain privileged information intended solely for the named addressee(s). It may not be used or disclosed except for the purpose for which it has been sent. If you are not the intended recipient you must not review, use, disclose, copy, distribute or take any action in reliance upon it. If you have received this communication in error, please notify Astex Therapeutics Ltd by emailing [EMAIL PROTECTED] and destroy all copies of the message and any attached documents. Astex Therapeutics Ltd monitors, controls and protects all its messaging traffic in compliance with its corporate email policy. The Company accepts no liability or responsibility for any onward transmission or use of emails and attachments having left the Astex Therapeutics domain. Unless expressly stated, opinions in this message are those of the individual sender and not of Astex Therapeutics Ltd. The recipient should check this email and any attachments for the presence of computer viruses. Astex Therapeutics Ltd accepts no liability for damage caused by any virus transmitted by this email. E-mail is susceptible to data corruption, interception, unauthorized amendment, and tampering, Astex Therapeutics Ltd only send and receive e-mails on the basis that the Company is not liable for any such alteration or any consequences thereof. Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Park, Cambridge CB4 0QA under number 3751674
